Skip to content
Clinical Trials – home
Research site

Niepubliczny Zaklad Opieki Zdrowotnej Przychodnia Specjalistyczna A Wittek H Rudzki Sp. j.

Poland Ul. Piotra Niedurnego 50 D, 41-709 Ruda Slaska, Poland

  • 4 trials recruiting
  • Obesity · Overweight · Type 2 diabetes mellitus
  • Adult patients

About Specializations

Niepubliczny Zaklad Opieki Zdrowotnej Przychodnia Specjalistyczna A Wittek H Rudzki Sp. j. in Ruda Slaska, Poland specialises in clinical trials of conditions such as Obesity, Overweight, Type 2 diabetes mellitus, Chronic kidney disease, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The site conducts research aimed at improving outcomes for patients with cardiovascular disease, including those at high risk of heart attacks or strokes, by testing innovative therapies that may lower event rates.

  • Evaluation of novel lipid‑lowering agents
  • Assessment of cardiovascular event reduction
  • Study of outcomes in atherosclerotic disease
  • Investigation of kidney‑related cardiovascular risk

Niepubliczny Zaklad Opieki Zdrowotnej Przychodnia Specjalistyczna A Wittek H Rudzki contributes to advancing heart health through these trials.

Nervous System Diseases

Trials at the clinic focus on alleviating painful symptoms of diabetic peripheral neuropathy, exploring new analgesic compounds that could enhance quality of life for affected adults.

  • Pain management strategies for diabetic neuropathy
  • Testing of emerging analgesic agents
  • Improving functional outcomes for patients with nerve pain

The research team of three investigators works to bring safer, more effective pain relief options to the community.

Nutritional and Metabolic Diseases

Studies address the growing burden of obesity, overweight, and type 2 diabetes by evaluating interventions that promote weight loss and better glycemic control.

  • Weight‑loss therapies for obesity and overweight
  • Combination treatments targeting diabetes and weight
  • Strategies to improve metabolic health
  • Long‑term management of chronic metabolic conditions

This research supports patients in achieving healthier body weight and blood sugar levels, reflecting the clinic’s commitment to metabolic well‑being.

Metabolism

The centre investigates how altering metabolic pathways can protect kidney function and reduce disease progression in individuals with chronic conditions.

  • Reduction of albuminuria in chronic kidney disease
  • Modulation of metabolic biomarkers in diabetes
  • Evaluation of renal outcomes linked to metabolic therapy
  • Exploration of novel mechanisms affecting metabolism

By linking metabolic research with cardiovascular and renal health, the site aims to deliver comprehensive benefits to patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Piotra Niedurnego 50 D41-709 Ruda SlaskaPoland
Recruiting now
4 trials
Conditions studied
8

More sites in Ruda SlaskaPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 SODIUM
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Obesity

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Dyslipidaemia

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Embonate
  • Sponsor:Novo Nordisk A/S

Obesity+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Diabetic neuropathy

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ly3556050
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.